Human IGF1 shRNA Lentivirus

SKU:BHV19400134
Suppliers
LipExoGen Biotech
LipExoGen Biotech
Details Products
Overview
Click light‑blue chips for details
The Human IGF1 shRNA Lentivirus delivers a validated short hairpin RNA achieving at least 70% knockdown of human insulin-like growth factor 1. Supplied as high-titer purified particles with a fluorescent reporter and selection marker, it efficiently transduces primary and thawed cells for stable loss-of-function studies of IGF1 signaling, cell growth, proliferation, and metabolism.
Species Human
Target Gene IGF1
Reporter GFP, GFP/Luc, RFP (+1 more)
Selection Blasticidin, Puromycin
Accession NM_001111283
Validation ≥70% Knockdown Validated
Format 3rd Gen, VSV-G Pseudotyped
Options selector
Catalog no. Reporter Selection Amount (TU)
LSV-0019-SET1 GFP
LSV-0019-SET2 RFP
LSV-0019-3S GFP/Luc
LSV-0019-4S RFP/Luc
LSV-0019-7S None
Available Options

Select the lentiviral variant that best fits your experiment. Availability and lead time may vary by option.

  • Options:
    • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
    • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
    • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 TU.
    • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
    • Includes GFP/Luc reporter; supplied as 2x10^6 TU.
    • Includes RFP/Luc reporter; supplied as 2x10^6 TU.
    • Includes GFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
    • Includes RFP reporter with Puromycin selection; supplied as 5x10^6 TU.
    • with Puromycin selection; supplied as 5x10^6 TU.
    • with Blasticidin selection; supplied as 5x10^6 TU.
  • Lead time: typically ships in ~7 business days; timing may vary by selected option.
  • Storage: store at -80°C
  • Shipping: Ships on dry ice
  • Upon receipt: follow the product datasheet storage instructions.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No LSV-0019
Accession Number NM_001111283
Product Type
  • Lentiviral Vector
  • shRNA Lentivirus
Reporter GFP, GFP/Luc, N/A, RFP, RFP/Luc
Selection Marker Blasticidin, N/A, Puromycin
Shipping Ships on dry ice; store at -80°C
Species Human

Background

IGF1 (insulin-like growth factor 1), also known as somatomedin-C, is a peptide hormone structurally related to insulin. Produced largely by the liver under growth hormone control, and also locally in many tissues, IGF1 acts through the IGF1 receptor tyrosine kinase to activate the PI3K-AKT and RAS-MAPK pathways. This signaling promotes cell proliferation, growth, survival, and differentiation, and IGF1 is a central mediator of postnatal somatic growth and tissue regeneration. Dysregulated IGF1 signaling is associated with growth disorders, metabolic disease, and cancer progression, making IGF1 an important target in endocrinology, metabolism, and oncology research.

Product Description & Applications

The Human IGF1 shRNA Lentivirus delivers a validated short hairpin RNA that achieves at least 70% knockdown of human insulin-like growth factor 1 (IGF1). The shRNA is expressed from a U6 promoter in a third-generation, self-inactivating lentiviral backbone, with a co-expressed fluorescent reporter (GFP or RFP, optionally with luciferase) and antibiotic selection marker for stable cell line generation. Knockdown is confirmed using a rapid fluorescence-based assay. The shRNA lentivirus set provides particles from a mix of two independent validated shRNAs plus a matched scrambled control. Applications include loss-of-function studies of IGF1 signaling in cell growth, proliferation, metabolism, and tumor biology. Particles are ultra-purified and concentrated to high titer by PEG precipitation and sucrose gradient centrifugation, transducing difficult-to-transfect cells, including primary and thawed cultures.

About This Product

This validated shRNA lentivirus targeting IGF1 (NCBI Accession: NM_001111283) delivers a 19–20 bp shRNA from a third-generation, self-inactivating lentiviral backbone. Expression is driven from a U6 Pol III promoter, with a constitutively expressed fluorescent reporter (GFP, GFP/Luc, RFP, RFP/Luc) and antibiotic selection marker (Blasticidin, Puromycin) co-expressed from the same vector. VSV-G pseudotyping enables broad cell tropism, including primary, suspension, and cryopreserved cell types.

Knockdown is validated using a proprietary bicistronic fluorescence assay in which the target mRNA is co-expressed fused to RFP alongside the shRNA-GFP construct. At least 70% reduction in RFP signal in GFP-positive cells confirms on-target activity — a more direct functional readout than transcript-level qPCR. Polyclonal stable lines can be generated by antibiotic selection within 10 days, preserving parental cell heterogeneity compared to single-clone CRISPR approaches.

What knockdown efficiency does this shRNA lentivirus achieve?
How was the shRNA construct validated?
What reporter and selection marker options are available?
What cell types are recommended for transduction?
Is a negative control lentivirus available?

Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.

Common customization requests

  • Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
  • Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
  • Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
  • Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
  • Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).

Add-ons you can request

  • Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
  • Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
  • Documentation: construct map/sequence confirmation package (as available) and batch documentation.

What to include in your request

  • Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
  • Insert sequence (FASTA) or reference ID, plus any required tags/mutations
  • Promoter, reporter, and selection marker preferences
  • Desired scale and preferred format (aliquots / concentration requests)

Email us at support@biohippo.com or use the Talk to a Scientist request form.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today